Cyclic AMP plays a pivotal role in neurite growth. During outgrowth, a trafficking system supplies membrane at growth cones. However, the cAMP-induced signaling leading to the regulation of membrane trafficking remains unknown. TC10 is a Rho family GTPase that is essential for specific types of vesicular trafficking. Recent studies have shown a role of TC10 in neurite growth in NGF-treated PC12 cells.
| INTRODUCTION
The vast surface expansion of neurons during the formation of axons and dendrites requires polarized transport of membrane and membrane proteins primarily at growth cones (Pfenninger, 2009; Wojnacki & Galli, 2016) . Membrane trafficking has also recently been recognized as an important player in axon guidance (Tojima & Kamiguchi, 2015; Wojnacki & Galli, 2016) . Plasmalemmal expansion in neurons consists of specific vesicle types being targeted to axons versus dendrites, long-range vesicle transport and subsequent vesicle insertion at growth tips (Ory & Gasman, 2011; Pfenninger & Friedman, 1993) . Neurite/axon outgrowth requires the regulation of cytoskeletal reorganization as well as membrane trafficking, and coordination between these processes is of critical importance. The understanding of signaling pathways from extracellular stimuli to the mechanisms regulating cytoskeletal reorganization during neuronal morphogenesis has markedly advanced in the past two decades (Hall & Lalli, 2010; Heasman & Ridley, 2008) . By contrast, the machineries that coordinate trafficking pathways during neurite outgrowth are yet to be fully elucidated, and thus, mechanisms linking membrane trafficking and cytoskeletal reorganization remain important elements to be determined.
Recent studies have emphasized the role of TC10, a Rho family GTPase, in membrane trafficking and neurite outgrowth (Bodrikov, Solis, & Stuermer, 2011; Dupraz et al., 2009; Fujita et al., 2013; Pommereit & Wouters, 2007) . TC10 and its effector Exo70 is localized to vesicular structures and the plasma membrane (Fujita et 2001). We previously investigated the molecular mechanism for the action of TC10 in NGF-induced neuritogenesis in PC12 cells, showing that NGF-induced activation of Rac1 transmits a signal through NADPH oxidase-reactive oxygen species (ROS)-Src family kinase to p190A activation and eventually down-regulates TC10 at the plasma membrane (Fujita et al., 2013) . Based on these results and those from another study from our group using EGF-treated HeLa cells (Kawase et al., 2006) , we have proposed a model in which the neuritogenesispromoting function of TC10 is executed by triggering vesicle fusion through the release of Exo70, a component of the exocyst tethering complex, after TC10 inactivation near the plasma membrane (Fig. S1 ). It is supposed that activated p190A in NGF-stimulated PC12 cells down-regulates RhoA concurrently with TC10 and thereby decreases F-actin contractility, contributing to neurite outgrowth. Considering a variety of neuritogenesis-promoting stimuli including cAMP, it is an important issue how broadly a similar coordinated regulation of membrane trafficking and cytoskeletal reorganization is preferred in neuronal cells.
In this study, we examined the molecular mechanism for the cAMP-induced down-regulation of TC10 in neuronal cells. Cyclic AMP exhibits profound effects on growth cone motility and guidance (Zheng, Zheng, & Poo, 1994; Shelly et al., 2010) by transmitting signals primarily through protein kinase A (PKA) and through exchange protein directly activated by cAMP (Epac; Bos, 2006; Fimia & Sassone-Corsi, 2001 ). Previous studies have linked elevated cAMP signaling with the enhancement of initial neuronal wiring during development (Piper, van Horck, & Holt, 2007) and with axon regeneration in the injured adult nervous system (Neumann, Bradke, TessierLavigne, & Basbaum, 2002; Qiu et al., 2002) . Similarly, TC10 could be involved in axon regeneration (Erschbamer, Hofstetter, & Olson, 2005; Tanabe et al., 2000) in addition to its role in neuritogenesis. In the present study using Förster resonance energy transfer (FRET)-based biosensors combined with RNAi techniques, we found that inactivation of TC10 and RhoA at the plasma membrane in cAMP-treated PC12 cells is mediated by the PKA-Sif-and Tiam1-like exchange factor (STEF)-Rac1-p190B pathway and contributes to neurite outgrowth. Although active Rac1 down-regulates TC10 and RhoA in both cAMP-and NGF-treated neuronal cells, these two types of treatments inactivate TC10 and RhoA through different signaling pathways.
| RESULTS

| Plasmalemmal TC10 activity in PC12
and Neuro2A cells rapidly decreases to a nadir after dbcAMP treatment Using a FRET-based biosensor, we examined the spatiotemporal change in TC10 activity at the plasma membrane for 30 min after dbcAMP treatment in PC12 cells (Figure 1a) .
The FRET/CFP ratio dropped to a nadir within 10 min after dbcAMP addition (Figure 1c ), in agreement with our previous result in PC12D cells (Fujita et al., 2013) . Similar inactivation of TC10 was observed in Neuro2A cells, another neuronal cell line (Figure 1d ). Although the time course of TC10 inactivation in cAMP-treated PC12 cells was very similar to that in NGF-treated PC12 cells (Fujita et al., 2013) , a marked spatial difference existed between the responses of TC10 activity to these treatments. In NGF-stimulated PC12 cells, the protruding sites showed a prominent localized decrease in TC10 activity, whereas the decreased GTP-TC10 in cAMPtreated cells occurred evenly throughout the cells (Figure 1a) . Two non-neuronal cell lines, HeLa (Figure 1b ,e) and COS-7 (Figure 1f ), displayed no change in plasmalemmal TC10 activity after dbcAMP treatment, although PKA activation after dbcAMP addition in these cells was confirmed using a PKA sensor (Komatsu et al., 2011) . The morphological response corresponded well to the change in TC10 activity. In NGFstimulated PC12 cells, rapidly repeated extension and retraction of protrusions occurred (Fujita et al., 2013) . The dbcAMP treatment induced a uniform expansion in the contours of naïve PC12 cells (Figure 1a and Fig. S2 ). No noticeable morphological change occurred in dbcAMP-treated HeLa cells (Figure 1b and Fig. S2 ). To find a further linkage between TC10 activity and neuritogenesis, we examined the spatial distribution of TC10 activity in extending neurites after dbcAMP treatment. Figure 1g shows that TC10 inactivation occurred over a growth cone, although a peripheral area tended to exhibit a clearer decrease in TC10 activity than the neck of the growth cone-like in case of NGF-induced neuritogenesis (Fujita et al., 2013) .
| TC10 depletion markedly reduces dbcAMP-induced neurite outgrowth
We next investigated cAMP-induced formation of mature neurites in PC12 cells with TC10 knocked down. We used an shRNA expression vector containing the pac gene to allow for selection of shRNA-expressing cells with puromycin. In TC10 shRNA-expressing cells, 70% of endogenous TC10 was depleted (Fig. S3a,b) . We determined neurite length using tubulin immunostaining. PC12 cells transfected with an empty shRNA vector developed neurites within 48 hr after dbcAMP addition (Figure 2a) . Depletion of TC10 strongly inhibited neurite outgrowth (Figure 2b ). The percentages of neurite-bearing cells were calculated in control and knockdown cells (Figure 2f) . In control cells, the percentage of neurite-bearing cells in the presence of dbcAMP was 63%. Only 7% of TC10 knockdown cells bore neurites in the presence of dbcAMP. The expression of shRNA-resistant wild-type TC10 (Fig. S3a ) restored neurite outgrowth ( Figure 2c,f) ; this excludes the possibility of offtarget effects by the shRNA used here.
Genes to Cells
To clarify the role of TC10 in neurite outgrowth, we investigated the effects of expressing a constitutively active or a dominant-negative mutant of TC10 in knockdown cells. A constitutively active mutant of TC10, TC10-Q75L, did not rescue the decrease in cAMP-induced neurite outgrowth by TC10 depletion (Figure 2d,f) . This suggests that GTP hydrolysis of TC10 near the plasma membrane in neuronal cells (Figure 1 ) is required for cAMP-induced neuritogenesis. Similarly, TC10-Q75L expression in 3T3-L1 cells severely impaired constitutive transport of the VSV-G protein to the plasma membrane (Kanzaki et al., 2002) . In the present study, a dominantnegative mutant of TC10, TC10-T31N, was also unable to rescue the reduction in cAMP-induced neuritogenesis F I G U R E 1 Spatiotemporal changes in TC10 activity at the plasma membrane after dbcAMP treatment in neuronal and non-neuronal cell lines.
(a, c) PC12 cells expressing Raichu-TC10/K-RasCT were starved for 30 min and then stimulated with 1 mM dbcAMP. Images were obtained every 2 min for 30 min after dbcAMP addition. (a) Representative images of the FRET/CFP ratio at the indicated times (in min) are shown in intensitymodulated display (IMD) mode. In IMD mode, eight colors from red to blue are used to represent the FRET/CFP ratio, with the intensity of each color indicating the mean intensity of FRET and CFP. The upper and lower limits of the ratio images are shown on the right. (c) Mean FRET/CFP ratios averaged over the whole cell were determined by measuring the relative decrease compared with the reference value, which was averaged over 10 min before dbcAMP stimulation. by TC10 depletion. This could be explained by the requirement of GTP-TC10 for the recruitment of Exo70 to the vesicles, as discussed previously (Fujita et al., 2013; Kawase et al., 2006) . By analogy to the results obtained in EGF-stimulated HeLa cells and NGF-treated PC12 cells, we presume that the GTP hydrolysis of TC10 in the proximity of the plasma membrane after cAMP treatment promotes neurite outgrowth by accelerating vesicle fusion at neurite tips (Fig. S1 ).
| dbcAMP-induced TC10 downregulation is mediated by PKA
To elucidate the mechanism for the dbcAMP-induced TC10 inactivation, we first examined the effects of the PKAspecific cAMP analogue 6-Bnz-cAMP (Christensen et al., 2003) and the Epac-specific cAMP analogue 007 (Enserink et al., 2002) on TC10 inactivation. The time course for the TC10 down-regulation within 30 min after 6-Bnz-cAMP treatment was similar to that observed in dbcAMP-treated cells (Figure 3a , left). The decrease in the lowest values of the FRET/CFP ratio after 6-Bnz-cAMP treatment was 86% of that in dbcAMP-treated cells (Figure 3a , right). By contrast, the average FRET/CFP ratio did not decrease after 007 addition.
A primary role of PKA in dbcAMP-induced TC10 inactivation was further confirmed by targeted depletion of PKA and Epac through RNA interference. The silencing effect of these shRNAs has been examined previously (Goto, Hoshino, Matsuda, & Nakamura, 2011) . Depletion of two isoforms (α and β) of the catalytic subunits of PKA, PRKACA and PRKACB, markedly reduced dbcAMP-induced TC10 inactivation in PC12 cells (Figure 3b , left). The decrease in the lowest values of the FRET/CFP ratio in the PRKACA-and PRKACBdepleted cells was 30% of that in dbcAMP-treated cells (Figure 3b, right) . By contrast, the mean decrease in the FRET/ CFP ratio was similar between control and Epac-depleted cells. Taken together, these results indicate that dbcAMP-induced TC10 inactivation is mediated by PKA in PC12 cells.
For EGF-treated HeLa cells and NGF-treated PC12 cells, a Rac1-NADPH oxidase-ROS-Src family kinase-p190A cassette mediates TC10 down-regulation upon stimulation (Fujita et al., 2013; Kawase et al., 2006) . To test the possibility that 
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cAMP-induced TC10 inactivation uses the same pathway, we examined the effect of apocynin, an inhibitor of ROS generation, on this inactivation. However, apocynin treatment did not inhibit cAMP-induced TC10 down-regulation ( Figure 3c ). Furthermore, PP2, a Src family kinase inhibitor, did not preclude TC10 inactivation in dbcAMP-treated PC12 cells (Figure 3d ). These results indicate that a difference exists in the signaling pathways between NGF-induced and dbcAMP-induced TC10 inactivation in PC12 cells.
| Plasmalemmal RhoA activity in PC12 and Neuro2A cells decreases to a nadir within 20-30 min after dbcAMP addition
To determine which molecules mediate cAMP-induced TC10 inactivation, we investigated the spatiotemporal change of RhoA activity in cAMP-treated PC12 cells. The plasmalemmal RhoA activity in PC12 cells dropped to a nadir within 20-30 min after dbcAMP addition (Figure 4a ,c). Similar inactivation of RhoA was observed in Neuro2A cells (Figure 4d ). The spatiotemporal change of RhoA activity in cAMP-treated PC12 cells was similar to that of TC10 activity, except that RhoA activity dropped more slowly than TC10 activity. This similarity prompted us to investigate whether RhoA activity in non-neuronal cells declines after dbcAMP addition. HeLa (Figure 4b ,e) and COS-7 cells (Figure 4f ) displayed no obvious change in plasmalemmal RhoA activity after dbcAMP treatment. These results indicate the possibility that GAPs which can inactivate RhoA also down-regulate TC10 in neuronal cells.
| Depletion of p190B markedly reduces dbcAMP-induced inactivation of TC10 and RhoA and neurite outgrowth in PC12 cells
We therefore examined the effect of depleting p190A or its close homologue p190B on cAMP-induced TC10 inactivation. As shown in Figure 5a , the expression of p190B (right) decreased the FRET/CFP ratio of both Raichu-TC10 and Raichu-RhoA in a dose-dependent manner. Under the condition used here, the number of FRET sensors per cell was more than 10-fold larger than that of endogenous RhoA or TC10 (S. Koinuma and T. Nakamura, unpublished data). Considering Genes to Cells KOINUMA et Al.
F I G U R E 5
Effect of depletion of p190A or p190B on dbcAMP-induced down-regulation of TC10 and RhoA. (a) Negative linear correlation between the FRET/CFP ratio of Raichu-TC10/K-RasCT and Raichu-RhoA/K-RasCT and the extent of the p190A (left) or p190B (right) co-expression. Raichu-Rac1/K-RasCT was used as an unresponsive control. The FRET/CFP ratio was obtained from spectrograms of 293-F cells cotransfected with pRaichu-TC10, pRaichu-RhoA, or pRaichu-Rac1 in combination with various amounts of pCXN2-5Myc-p190A or pCMV-Flag-p190B. Error bars show SE (n = 3). (b) p190A (top) and p190B (bottom) expression in control and knockdown cells was analyzed by immunoblotting. Experiments were repeated twice. siRNA-1 (for p190A) and siRNA-2 (for p190B) showed higher knockdown efficiency and were used for further experiments. (c) PC12 cells were transfected with pRaichu-TC10/K-RasCT. After recovery, the cells were further transfected with p190A or p190B siRNA. After incubation for 3 days, the cells were serum starved for 30 min and then imaged every 2 min for 30 min after dbcAMP addition. Left, mean FRET/CFP ratios averaged over the whole cell are expressed as in the legend to Figure 1c . Right, data in the bar graph represent the average and SE of the lowest values of the FRET/CFP ratio of Raichu-TC10 in the indicated samples. (d) PC12 cells were transfected with pRaichu-RhoA/K-RasCT. After recovery, the cells were similarly treated and analyzed as in (c). Left, mean FRET/CFP ratios averaged over the whole cell are expressed as in the legend to Figure 1c . Right, data in the bar graph represent the average and SE of the lowest values of the FRET/CFP ratio of Raichu-RhoA in the indicated samples. At least ten cells were assessed in each experiment, and the experiments were repeated more than three times. Error bars show SE. Symbols indicate the result of a one-way ANOVA followed by Dunnett's post hoc test (*p < .05; **p < .01; n.s., not significant; e, f) PC12 cells expressing p190A (e) or p190B (f) along with mCherry-K-RasCT were mock-treated or treated with dbcAMP for 20 min and then immunostained. Left, representative p190A (e) or p190B (f) confocal images are shown with mCherry-K-RasCT images. Right, a bar graph depicts the normalized level of p190A (e) or p190B (f) at the plasma membrane in the PC12 cells with or without dbcAMP treatment. Ten cells were assessed in each experiment, and the experiments were repeated three times. Symbols indicate the result of a one-way ANOVA followed by Bonferroni's post hoc test (**p < .01; n.s., not significant) this dominance of FRET sensors, it is plausible that most of the decrease in the FRET/CFP ratio of Raichu-TC10 in response to the increase in p190B comes from a direct action of p190B to TC10. Together, p190B has GAP activity at TC10 and RhoA as well as p190A (Figure 5a, left) . In PC12 cells transfected with siRNA against p190A or p190B, 80% of p190A (siRNA-1) or 75% of p190B (siRNA-2) was depleted (Figure 5b and Fig. S4a,b) . Then, we examined the effect of depletion of p190A or p190B on cAMP-induced TC10 inactivation. In p190B knockdown cells, the decrease in the lowest values of TC10 activity was 40% of that in control cells (Figure 5c ). By contrast, the decrease in TC10 activity in p190A knockdown cells was 94% of that in control cells. Considering the knockdown efficiency, these data strongly suggest that p190B is the GAP mainly responsible for dbcAMP-induced TC10 inactivation. Next, we investigated the effect of depletion of p190A or p190B on cAMPinduced RhoA inactivation. The decrease in the lowest values of RhoA activity in p190B-depleted cells was 48% of that in control cells (Figure 5d ). The decrease in the lowest values of RhoA activity was similar in control and p190A-depleted cells. To confirm the specific contribution of p190B to TC10/ RhoA inactivation in cAMP-treated cells, we examined the relocalization of p190A or p190B in response to dbcAMP (Figure 5e ,f). In the absence of cAMP, both p190A and p190B were mainly located in the cytosol of PC12 cells. Upon dbcAMP treatment, p190B, but not p190A, was efficiently recruited to the plasma membrane.
| Depletion of p190A and p190B reduced dbcAMP-induced neurite outgrowth through different mechanisms
We next investigated dbcAMP-induced formation of mature neurites in p190A or p190B knockdown cells. PC12 cells transfected with control siRNA developed neurites within 48 hr after dbcAMP addition (Figure 6a, left) . By contrast, depletion of p190B markedly inhibited neurite outgrowth (Figure 6a , right). Though less than the effect of p190B depletion, p190A depletion considerably decreased cAMP-induced neuritogenesis. The percentages of neurite-bearing cells were calculated in control and knockdown cells (Figure 6b) . In control cells, 70% of the cells bore neurites in the presence of dbcAMP, whereas only 27% or 16% of p190A-or p190B-depleted cells bore neurites even in the presence of dbcAMP. The substantial decrease in cAMP-induced neurite outgrowth in p190A knockdown cells (Figure 6 ) appears inconsistent with the inefficiency of p190A depletion on cAMP-induced inactivation of TC10 and RhoA (Figure 5c,d) . However, we think that the paradoxical effects of p190A depletion can be explained by the following difference in sites of action between p190A and p190B. In p190A knockdown Genes to Cells
cells, the augmented cortical actin network blocked the formation of initial protrusions. In contrast, p190B depletion inhibited neurite outgrowth through blocking cAMPdependent TC10/RhoA inactivation at neurite tips. This view is supported by three findings. First, we examined the number of initial protrusion events from cell bodies by timelapse imaging of F-actin during 48 hr after dbcAMP addition (Figure 7a,b) . Control PC12 cells formed unstable protrusions frequently. In this condition, we rarely observed an extension of stabilized neurites. In p190A knockdown cells, there existed prominent cortical actin network at the edge of cell bodies, and protrusions were rarely formed throughout the imaging. In p190B knockdown cells, the frequency of initial protrusion was similar to that in control cells. Second, we examined the level of cortical actin by phalloidin staining in the absence of dbcAMP. F-actin signal in p190A knockdown cells was clearly stronger than that in control and p190B knockdown cells (Figure 7c ). Third, in the FRET imaging experiments shown in Figure 5d , the unnormalized level of basal RhoA activity in p190A knockdown cells was significantly higher than that in control cells (Fig. S4c) , whereas the unnormalized level of basal RhoA activity in p190B knockdown cells was similar to that in control cells. However, as shown in Figure 5c ,d, p190A depletion had negligible effect on the relative cAMP-dependent decrease in TC10 and RhoA activity. Therefore, cAMP-dependent regulation of TC10 and RhoA was executed by p190B, but not by p190A. Together, these data led us to conclude that p190B is the GAP mostly likely responsible for dbcAMP-induced down-regulation of TC10 and RhoA and that p190B plays a critical role in neurite outgrowth upon dbcAMP treatment in PC12 cells.
| dbcAMP-induced TC10 inactivation is dependent on STEF and Rac1
Because p190B has no canonical PKA phosphorylation motif, we searched for other mediators, which links between PKA and p190B. In Figure 5f , we found that p190B was recruited to the plasma membrane upon dbcAMP treatment. Bustos, Forget, Settleman and Hansen (2008) have reported that active Rac1 recruits p190B to the plasma membrane through direct binding to the middle domain of p190B and thereby increases p190B activity. We thus examined the effects of a dominant-negative mutant of Rac1, Rac1-N17, on TC10 inactivation after dbcAMP addition. Rac1-N17 markedly inhibited dbcAMP-induced TC10 down-regulation ( Figure 8a ). Our previous study has shown that phosphorylation of STEF by PKA is crucial to dbcAMP-induced Rac1 activation and neurite outgrowth in PC12 cells (Goto et al., 2011) . Therefore, it was plausible that the PKA-STEF-Rac1-p190B pathway was involved in dbcAMP-induced TC10 inactivation at the plasma membrane. As expected, depletion of STEF with shRNA ( Fig. S3c ) strongly blocked the dbcAMPinduced TC10 inactivation (Figure 8b ). In conclusion, we argue that the PKA-STEF-Rac1-p190B pathway (Figure 8c) is critical for dbcAMP-induced TC10 inactivation and neurite outgrowth.
| DISCUSSION
In this study, we showed that cAMP-induced downregulation of plasmalemmal TC10 and RhoA in neuronal cell lines is mediated by the PKA-STEF-Rac1-p190B pathway; the concurrent inactivation of TC10 and RhoA at neurite tips can be implicated in neurite outgrowth through membrane addition and a decrease in F-actin contractility. This is supported by our findings that (i) cAMP treatment decreased the activities of TC10 and RhoA near the plasma membrane in PC12 and Neuro2A cells, and particularly, TC10 activity was locally down-regulated at extending neurite tips in cAMPtreated PC12 cells.
(ii) dbcAMP-induced TC10 inactivation was mediated by PKA in PC12 cells, (iii) p190B depletion efficiently reduced cAMP-induced down-regulation of TC10 and RhoA, and severely hampered cAMP-induced neurite outgrowth in PC12 cells, (iv) p190B was specifically recruited to the plasma membrane upon dbcAMP treatment in PC12 cells, and (v) dbcAMP-induced TC10 inactivation was dependent on STEF and Rac1. The importance of coordinated regulation between membrane trafficking and cytoskeletal reorganization in axon/neurite outgrowth has been emphasized in recent published reports (Pfenninger, 2009; Wojnacki & Galli, 2016) , and we believe that the signaling pathway shown here, cAMP-PKA-STEF-Rac1-p190B-TC10/RhoA (Figure 8c) , is a plausible mechanism for this type of coordination.
High levels of STEF and p190B expression in neuronal tissues may explain the result that the cAMP-PKA-STEFRac1-190B-TC10/RhoA pathway was regionally restricted, including neuronal cells. STEF has been reported to be predominantly expressed in the developing brain (Hoshino et al., 1999) . Likewise, it has been reported that p190B is principally expressed in developing and adult brains (Matheson et al., 2006) . The pan-neuronal expression of STEF and p190B suggests that the PKA-STEF-Rac1-190B pathway in the regulation of TC10 and RhoA activities may be used in a broad range of neuronal tissues. Although, in this study, dbcAMP treatment in HeLa and COS-7 cells did not change plasmalemmal activities of RhoA as well as TC10, previous studies have shown that cAMP-PKA inhibited RhoA activation in several non-neuronal situations including leukocyte adhesion (Laudanna, Campbell, & Butcher, 1997) and endothelial barrier control (Qiao, Huang, & Lum, 2003) . One plausible explanation is RhoA phosphorylation by PKA; RhoA is phosphorylated on Ser-188, close to its CAAX box, by PKA (Lang et al., 1996) . It has been reported that this phosphorylation does not perturb the action of GEF and GAP at RhoA, but inhibits the activity of RhoA by enhancing its interaction with RhoGDI (Ellerbroek, Wennerberg, & Burridge, 2003) . The RhoA sensor used here contains the carboxyl-terminal regions of K-Ras and does not bind to RhoGDI (Yoshizaki et al., 2003) ; therefore, this sensor can monitor the balance between GEF and GAP activities acting on RhoA, independently of the phosphorylation status of Ser-188 on RhoA. As far as we know, no report has shown TC10 phosphorylation by PKA, and TC10 has no canonical PKA phosphorylation motif. Thus, the evaluation of TC10 activity using the TC10 sensor in cAMP-treated cells can be carried out without considering direct phosphorylation of TC10 by PKA.
Our finding that p190B, but not p190A, mediates cAMPinduced inactivation of TC10 and RhoA provides a novel example of a difference in cellular functions between the two p190 proteins. This p190B isoform-specific function can be explained by the mechanism that active Rac1 interacts with p190B thereby up-regulating its GAP activity (Bustos et al., 2008) . Similarly, Ponik, Trier, Wozniak, Eliceiri and Keely (2013) have recently reported that p190B, but not p190A, mediates RhoA inactivation during ductal formation in a three-dimensional microenvironment and argued that this could be explained by the specific binding of Rac1-GTP to p190B. In PC12 cells, the reduction of cAMP-induced RhoA inactivation by p190B depletion was significant, but not large. We suppose that another neurally enriched GAP inactivates RhoA along with p190B after cAMP treatment. Mice lacking p190B are 30% reduced in size (Sordella et al., 2002) and present neurodevelopmental defects, such as malformation of major forebrain commissures and dilation of the lateral ventricle (Matheson et al., 2006) . Although expression profiles of the two p190 proteins are quite similar (Brouns et al., 2000; Matheson et al., 2006) , p190B deficiency results in gross defects that are similar to, but distinct from, those observed in the absence of p190A (Matheson et al., 2006) . These results are consistent with the idea that p190A and p190B are involved in distinct cellular signaling pathways. Further molecular/cellular comparisons between p190A and p190B isoforms will be required for understanding the difference in the neuronal defects found in p190A-and p190B-deficient mice.
Although we have previously shown that NGF-induced TC10 inactivation is mediated by the active Rac1-NADPH oxidase-ROS-Src family kinase-p190A pathway (Fujita et al., 2013) , here we showed that cAMP-induced TC10 inactivation is mediated by Rac1-p190B binding. This divergence can be explained by the idea that Rac1 exerts distinct functions in different cellular locations through a variety of effectors (Heasman & Ridley, 2008) and several modifications of Rac1 itself (Hodge & Ridley, 2016) . Additionally, it has been reported that cAMP inhibits NADPH oxidase activation in a lymphoid cell line (Burkey & Webster, 1993) ; thus, this inhibition may change the direction of the cAMP signal to other pathways, including Rac1-p190B. Although Bustos et al. (2008) have shown that active Rac1 recruits p190B into a detergent-insoluble plasma membrane component, further details will need to be clarified to understand how the distinction between the Rac1-NADPH oxidase pathway and the Rac1-p190B pathway is made depending on extracellular stimuli.
TC10 has been implicated as playing a role in a variety of physiological functions, such as insulin-induced GLUT4 translocation , neurite/axon outgrowth (Dupraz et al., 2009; Fujita et al., 2013) and neurotransmission of inhibitory synapse (Mayer et al., 2013) ; however, to date, the majority of TC10 functional analyses have been carried out at the cellular level. Therefore, future animal studies are expected to elucidate in vivo functions that are predictable, at least in part, from cellular experiments, including this study. We have previously developed FRET sensors for TC10 and visualized its activity in various imaging set ups (Fujita et al., 2013; Kawase et al., 2006) . The combination of animal studies and advanced imaging techniques should help clarify the molecular mechanisms underlying the higher-order functions of TC10.
| EXPERIMENTAL PROCEDURES
| FRET biosensors
The plasmids encoding the FRET biosensors, Raichu-TC10/K-RasCT (1096kx), Raichu-RhoA/K-RasCT (1293x), Raichu-Rac1/K-RasCT (1011x) and pAKAR3-3536NES have been described previously (Itoh et al., 2002; Kawase et al., 2006; Komatsu et al., 2011; Yoshizaki et al., 2003) . These sensors contain the carboxyl-terminal region of K-Ras (K-RasCT) and thereby are localized to the plasma membrane. An excess of signals from intracellular compartments profoundly decrease the signal-to-noise ratio. The use of these K-RasCT-containing sensors circumvents this problem.
| Plasmids
The RNA targeting constructs against TC10, PKA catalytic subunit α (PRKACA), PKA catalytic subunit β (PRKACB), Epac1, Epac2 and STEF have been described previously (Fujita et al., 2013; Goto et al., 2011) . pCXN2-5Myc-p190A (Kawase et al., 2006) and pCAGGS-Lifeact-mEGFP (Riedl et al., 2008) were provided by Dr M. Matsuda (Kyoto University). pFLAG-CMV2-p190B (Bustos et al., 2008 ) was a gift from Dr J. Settleman (Harvard Medical School). The cDNAs coding a full-length human TC10 (205 amino acids) and its mutants were point-mutated to resist short-hairpin RNA-mediated knockdown and subcloned into pCAGGS. pERedNLS-Rac1-S17N has been described previously (Aoki, Nakamura, & Matsuda, 2004) . pCAGGS-mCherry-KRasCT encoded mCherry fused to K-RasCT.
| Cells, reagents and antibodies
PC12 cells (Nakamura et al., 1999) were maintained in RPMI medium (Life Technologies, Carlsbad, CA, USA) supplemented with 10% horse serum and 5% FBS. The cells were plated on 35-mm glass-base dishes (Asahi Techno Glass, Shizuoka, Japan) coated with polyethyleneimine (Sigma-Aldrich, St Louis, MO, USA). If necessary, the glass-base dishes were additionally coated with laminin (Life Technologies). Neuro2A cells (Aoki et al., 2002) , which were provided by Dr H. Kiyama, were maintained in DMEM/F-12 + GlutaMAX (Life Technologies) containing 10% FBS. HeLa and COS-7 cells (Komatsu et al., 2011) were maintained in DMEM containing 10% FBS. 293-F cells (Life Technologies) were maintained in FreeStyle 293 expression medium (Life Technologies). dbcAMP and PP2 were purchased from Calbiochem. Puromycin and N 6 -benzoyladenosine-3′,5′-cyclical monophosphate (6-Bnz-cAMP) were obtained from Sigma-Aldrich. 8-pa ra-chloro-phenyl-thio-2′-O-methyl-cAMP (007) was obtained from Tocris Cookson (Ballwin, MO, USA). Apocynin was purchased from Tokyo Chemical Industry (Tokyo, Japan). Alexa Fluor 488 Phalloidin and DAPI came from Thermo Fisher Scientific (Waltham, MA, USA) and Dojindo (Kumamoto, Japan), respectively. The following primary antibodies were used: mouse mAb to p190A (1:1,000 dilution, BD Biosciences ® Thermo Fisher Scientific); mouse mAb to p190B (G-11, 1:1,000 dilution, Santa Cruz Biotechnology, Santa Cruz, CA, USA); rabbit polyclonal antibodies to GAPDH (1:1,000 dilution, Santa Cruz Biotechnology); rabbit polyclonal antibodies to TC10 (1:1,000 dilution, Proteintech, Rosemont, IL, USA). Mouse mAb to α-tubulin (1:1,000 dilution, a gift from Dr T. Arai, Tokyo University of Science; Arai & Matsumoto, 1988) .
| RNA interference
Stealth siRNAs against p190A and p190B were obtained from Life Technologies. The 25-mer nucleotide sequence (sense) to target rat p190A mRNA was 5′-CCUCCCUGUCCAAAGAUCAUUCCAA-3′ and to target rat p190B mRNA was 5′-UCCCAGAUGAUAGUCAG AAUCGAAU-3′. PC12 cells were transfected with 20 nM siRNA using Lipofectamine 2000 (Life Technologies) according to the manufacturer's instructions and used after 72 hr of incubation.
| In vitro spectrofluorometry
At 48 hr after transfection, 293-F cells were transferred into a quartz cuvette and fluorescence spectra were obtained using an FP-750 spectrometer (JASCO, Hachioji, Japan) at an excitation wavelength of 433 nm. In combination with CAG promoter (Niwa, Yamamura, & Miyazaki, 1991) , a high transfection-efficiency using 293-F cells greatly increased the expression of FRET sensors (Nakamura, Kurokawa, Kiyokawa, & Matsudam, 2006) . The number of FRET sensors per cell was 10-to 100-fold larger than that of endogenous signaling molecules. Due to the quantitative dominance of FRET sensors, the influence of endogenous signaling molecules on the response of sensors was small, if any.
| Neurite outgrowth assay
PC12 cells were transfected with the pSUPER constructs or siRNAs and then selected with 2 μg/ml puromycin for 2 days, if necessary. Neurite outgrowth was induced with 1 mM
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dbcAMP and allowed to proceed for 48 hr in RPMI medium containing 0.1% BSA and 2 μg/ml puromycin. Thereafter, cells were fixed with 3.7% formaldehyde and permeabilized with 0.2% Triton X-100. After being soaked in phosphatebuffered saline containing 3% BSA for 1 hr, the samples were incubated overnight with an antitubulin antibody and then incubated for 1 hr with Alexa Fluor 488-conjugated antimouse IgG secondary antibody with DAPI (1:1,000 dilution). The samples were imaged with an IX81 inverted microscope (Olympus, Tokyo, Japan) with an FV-1000 confocal imaging system (Olympus). The dead or unhealthy cells were excluded by sight. Quantification of neurite outgrowth was carried out as described previously (Nakamura et al., 2002) .
| Time-lapse imaging
PC12 cells expressing FRET sensors were serum starved for 30 min with phenol red-free DMEM/F-12 medium containing 0.1% BSA and then treated with cAMP analogues. The medium was covered with mineral oil (Sigma-Aldrich) to preclude evaporation. Cells were imaged with an IX81 inverted microscope (Olympus) equipped with a Cool SNAP-HQ cooled charge-coupled device camera (Roper Scientific, Trenton, NJ, USA), a laser auto-focusing system (IX2-ZDC, Olympus) and an automatically programmable XY stage (MD-XY30100T-Meta, SIGMA KOKI, Tokyo, Japan), which allowed for the capture of time-lapse images of several fields of view in a single experiment. The following filters were used for dual-emission imaging: an FF01-438/24-25 excitation filter (Semrock); an XF2034 (455DRLP) dichroic mirror (Omega Optical, Brattleboro, VT, USA); two emission filters (FF01-483/32-25 for cyan fluorescent protein (CFP) and FF01-542/27-25 for FRET, Semrock, Rochester, NY, USA). Cells were illuminated with an X-Cite 120LED (Lumen Dynamics, Mississauga, ON, Canada) and viewed through a plan apochromat 60× oil objective lens (NA 1.4, Olympus). The exposure times for 4 × 4 binning were 200 ms for CFP and FRET images and 50 ms for differential interference contrast (DIC) images. After background subtraction, FRET/CFP ratio images were created with the MetaMorph software (Universal Imaging, West Chester, PA, USA), and the images were used to represent FRET efficiency.
| Immunocytochemistry and image analysis
Cells were fixed with 3.7% formaldehyde and permeabilized with 0.2% Triton X-100. After being soaked in phosphatebuffered saline containing 3% BSA for 1 hr, the samples were incubated overnight with a primary antibody and then incubated for 1 hr with fluorescent secondary antibody (conjugated to Alexa Fluor 488, Thermo Fisher Scientific). The samples were imaged with an IX81 inverted microscope equipped with an FV-1000 confocal imaging system. Localization of p190A or p190B to the plasma membrane was quantitated with the MetaMorph software as follows: mCherry fused to K-RasCT was localized to the plasma membrane, and thus, the outer outline of mCherry-positive region was drawn by hand. The second outline was created at 5-pixel inside of the first outline using Euclidian distance command. The third outline was similarly created at 10 pixels inside of the first outline. The stripe area between the first and the second outline included the plasma membrane and the stripe area between the second and the third outline was used as a control. The localization of p190 was determined by the signal in the plasma membrane area which was normalized by the cytoplasmic p190 signal in the control area.
| Quantitative RT-PCR
Total RNA from PC12 cells expressing the indicated shRNAs was extracted using RNeasy (Qiagen, Hilden, Germany) and used for cDNA synthesis using a Transcriptor first strand cDNA synthesis kit (Roche, Basel, Switzerland). Quantitative real-time PCR was carried out with the Power SYBR Green PCR Master Mix (Applied Biosystems ® , Thermo Fisher Scientific) and a 7500 Fast Real-Time PCR system (Applied Biosystems ® , Thermo Fisher Scientific) according to the method described previously (Nojima et al., 2011) .
| Statistical analysis
One-way ANOVA followed by Dunnett's or Bonferroni post hoc test was carried out using GraphPad PRISM (version 5.04, GraphPad Software, La Jolla, CA, USA).
